162 related articles for article (PubMed ID: 2170703)
1. [Anticoagulant therapy in obstetrical disorders].
Murata M; Hayakawa M; Goto K; Isobe K; Matuura T; Hirano H; Higuchi M; Maki M
Rinsho Ketsueki; 1990 Jun; 31(6):763-8. PubMed ID: 2170703
[TBL] [Abstract][Full Text] [Related]
2. Gabexate as a therapy for disseminated intravascular coagulation.
Umeki S; Adachi M; Watanabe M; Yaji S; Soejima R
Arch Intern Med; 1988 Jun; 148(6):1409-12. PubMed ID: 3132124
[TBL] [Abstract][Full Text] [Related]
3. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
Nishiyama T; Kohno Y; Koishi K
Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
[TBL] [Abstract][Full Text] [Related]
4. [Heparin, low molecular weight heparin, heparinoid, and antithrombin III therapy of disseminated intravascular coagulation].
Nakagawa M
Nihon Rinsho; 1993 Jan; 51(1):87-92. PubMed ID: 7679453
[TBL] [Abstract][Full Text] [Related]
5. Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia.
Kupferminc M; Rimon E; Many A; Maslovitz S; Lessing JB; Gamzu R
Blood Coagul Fibrinolysis; 2011 Mar; 22(2):123-6. PubMed ID: 21192252
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of FOY therapy for DIC or pre-DIC associated with neurosurgical disease].
Wakui K; Takemae T; Kobayashi S
No Shinkei Geka; 1990 Jul; 18(7):609-17. PubMed ID: 2118601
[TBL] [Abstract][Full Text] [Related]
7. [Principles of the therapy for disseminated intravascular coagulation: current status and new trends].
Takahashi H
Nihon Rinsho; 1993 Jan; 51(1):79-86. PubMed ID: 7679452
[TBL] [Abstract][Full Text] [Related]
8. Treatment of disseminated intravascular coagulation with gabexate mesilate.
Tamaki S; Wada H; Hiyoyama K; Shimura M; Minamikawa K; Wakita Y; Nakase T; Ohiwa M; Kaneko T; Iwasaki E
Clin Ther; 1993; 15(6):1076-84. PubMed ID: 8111805
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of antithrombin III concentrate (BI 6.013) for disseminated intravascular coagulation in obstetrics. Well-controlled multicenter trial.
Maki M; Terao T; Ikenoue T; Takemura T; Sekiba K; Shirakawa K; Soma H
Gynecol Obstet Invest; 1987; 23(4):230-40. PubMed ID: 3111953
[TBL] [Abstract][Full Text] [Related]
10. [Therapy of disseminated intravascular coagulation].
Matsuda T
Rinsho Byori; 1985 Jun; Spec No 63():79-89. PubMed ID: 3930817
[No Abstract] [Full Text] [Related]
11. [Disseminated intravascular coagulation (DIC) after artificial valve replacement: especially tricuspid regurgitation].
Satokawa H; Iwaya F; Igari T; Abe T; Hagiwara K; Tanji M; Watanabe M; Midorikawa H; Sato Y; Takase S
Kyobu Geka; 1990 Apr; 43(4):271-5. PubMed ID: 2112659
[TBL] [Abstract][Full Text] [Related]
12. Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis.
Taenaka N; Shimada Y; Hirata T; Nishijima MK; Takezawa J; Yoshiya I; Kambayashi J
Crit Care Med; 1983 Sep; 11(9):735-8. PubMed ID: 6411432
[TBL] [Abstract][Full Text] [Related]
13. [Fundamental studies on the management of disseminated intravascular coagulation (DIC) with antithrombin III (AT-III) concentrate].
Gotoh K
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Apr; 37(4):571-80. PubMed ID: 3989338
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of antithrombin replacement therapy in severe early-onset preeclampsia.
Nakabayashi M; Asami M; Nakatani A
Semin Thromb Hemost; 1999; 25(5):463-6. PubMed ID: 10625203
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of disseminated intravascular coagulation (DIC) or pre-DIC with gabexate mesilate (FOY)].
Wada H; Suzuki H; Mori Y; Deguchi A; Oukubo I; Tsuda M; Tanaka I; Deguchi K; Shirakawa S; Minami N
Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):67-73. PubMed ID: 3132518
[No Abstract] [Full Text] [Related]
16. Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion.
Büller HR; Weenink AH; Treffers PE; Kahlé LH; Otten HA; ten Cate JW
Scand J Haematol; 1980 Jul; 25(1):81-6. PubMed ID: 7444377
[TBL] [Abstract][Full Text] [Related]
17. Disseminated intravascular coagulation after hepatic resection.
Tsuzuki T; Toyama K; Nakayasu K; Iida S; Ueda M; Toizumi A
Surgery; 1990 Feb; 107(2):172-6. PubMed ID: 2154054
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of disseminated intravascular coagulation].
Asakura H
Rinsho Ketsueki; 1990 Jun; 31(6):756-62. PubMed ID: 2214166
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of low molecular weight heparin in a canine model of thromboplastin-induced acute disseminated intravascular coagulation.
Mischke R; Fehr M; Nolte I
Res Vet Sci; 2005 Aug; 79(1):69-76. PubMed ID: 15894027
[TBL] [Abstract][Full Text] [Related]
20. The course of disseminated intravascular coagulation is predicted by changes in thrombin-antithrombin III complex levels--is there any difference between treatment with standard heparin or low-molecular-weight heparin?
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Blood Coagul Fibrinolysis; 1991 Oct; 2(5):623-7. PubMed ID: 1664251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]